A Better Interferon?
Subcutaneous injections of pegylated interferon β-1a once every 2 weeks may improve recovery from relapses and increase the likelihood of freedom from measurable disease activity
Pegylated interferon β-1a continues to show benefits similar to other currently available...
Clinical Research, Drug Development, Meetings